Publications

1. Alrehaili G, Kemppainen J, Kalra S, Pinto E Vairo F, Moua T, Yi ES, Ferrer A, Patnaik MM, Carmona EM. Genetic Testing Goes Beyond Imaging and Histological Evaluation in Pleuroparenchymal Fibroelastosis. Lung. 2024 Apr; 202(2):151-156. Epub 2024 Mar 10.
   View PubMed
2. Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS Trial Investigators . Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease. Rheumatology (Oxford). 2024 Mar 1; 63 (3):639-647
   View PubMed
3. Duke JD, Roy M, Daley S, Hoult J, Benzo R, Moua T. Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study. ERJ Open Res. 2024 Mar; 10 (2) Epub 2024 Mar 25
   View PubMed
4. Petnak T, Cheungpasitporn W, Thongprayoon C, Sodsri T, Tangpanithandee S, Moua T. Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis. Respir Res. 2024 Jan 18; 25 (1):41
   View PubMed
5. Fernandez Perez ER, Leach SM, Vestal B, PREDICT Study Investigators and Collaborators: . Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study. ERJ Open Res. 2024 Jan; 10 (1) Epub 2024 Jan 08
   View PubMed
6. Duke JD, Moua T, Ridgeway JL, Roy M, Benzo M, Hoult J, Benzo R. Home-Based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease: IMPLEMENTATION AND QUALITATIVE ASSESSMENT OF A PILOT TELEHEALTH PROGRAM. J Cardiopulm Rehabil Prev. 2023 Jul 1; 43 (4):270-276 Epub 2023 Jan 12
   View PubMed
7. Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS, ISABELA 1 and 2 Investigators. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials. JAMA. 2023 May 9; 329 (18):1567-1578
   View PubMed
8. Hill ML, Moua T. 73-Year-Old Man With Dyspnea and Cough. Mayo Clin Proc. 2023 May; 98 (5):789-794 Epub 2023 Apr 05
   View PubMed
9. Matson SM, Baqir M, Moua T, Marll M, Kent J, Iannazzo NS, Boente RD, Donatelli JM, Dai J, Diaz FJ, Demoruelle MK, Hamblin MB, Mathai SK, Ryu JH, Pope K, Walker CM, Lee JS. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory. Chest. 2023 Apr; 163 (4):861-869 Epub 2022 Dec 05
   View PubMed
10. Taweesedt P, Lertjitbanjong P, Eksombatchai D, Charoenpong P, Moua T, Thongprayoon C, Tangpanithandee S, Petnak T. Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis. J Clin Med. 2023 Jan 13; 12 (2)
    View PubMed
11. Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna D. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 9; 24 (1):6 Epub 2023 Jan 09
    View PubMed
12. Pornchai A, Moua T. Dyspnea and cough in a 68-year-old female with light chain deposition disease. Respir Med Case Rep. 2023; 43:101839 Epub 2023 Mar 20
    View PubMed
13. Koo CW, Williams JM, Liu G, Panda A, Patel PP, Frota Lima LMM, Karwoski RA, Moua T, Larson NB, Bratt A. Quantitative CT and machine learning classification of fibrotic interstitial lung diseases. Eur Radiol. 2022 Dec; 32 (12):8152-8161 Epub 2022 June 09
    View PubMed
14. Petnak T, Thongprayoon C, Baqir M, Ryu JH, Moua T. Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis. Eur Respir J. 2022 Oct; 60 (4) Epub 2022 Oct 06
    View PubMed
15. Bratt A, Williams JM, Liu G, Panda A, Patel PP, Walkoff L, Sykes AG, Tandon YK, Francois CJ, Blezek DJ, Larson NB, Erickson BJ, Yi ES, Moua T, Koo CW. Predicting usual interstitial pneumonia histopathology from chest CT imaging with deep learning. Chest. 2022 Oct; 162 (4):815-823 Epub 2022 Apr 08
    View PubMed
16. Roden AC, Boland JM, Johnson TF, Aubry MC, Lo YC, Butt YM, Maleszewski JJ, Larsen BT, Tazelaar HD, Khoor A, Smith ML, Moua T, Jenkins SM, Moyer AM, Yi ES, Bois MC. Late Complications of COVID-19. Arch Pathol Lab Med. 2022 Jul 01; 146(7):791-804.
    View PubMed
17. Zhao Y, Gao Y, Petnak T, Cheungpasitporn W, Thongprayoon C, Zhang X, Moua T. Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis. Respir Res. 2022 Jun 21; 23 (1):164 Epub 2022 June 21
    View PubMed
18. Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM, 1305-0013 Trial Investigators. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 Jun 9; 386 (23):2178-2187 Epub 2022 May 15
    View PubMed
19. Wijsenbeek M, Molina-Molina M, Chassany O, Fox J, Galvin L, Geissler K, Hammitt KM, Kreuter M, Moua T, O'Brien EC, Slagle AF, Krasnow A, Reaney M, Baldwin M, Male N, Rohr KB, Swigris J, Antoniou K. Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Res. 2022 Apr; 8 (2) Epub 2022 May 03
    View PubMed
20. Moua T, Petnak T, Charokopos A, Baqir M, Ryu JH. Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches. J Clin Med. 2022 Mar 8; 11 (6) Epub 2022 Mar 08
    View PubMed
21. Flaherty KR, Wells AU, Cottin V, Devaraj A, Inoue Y, Richeldi L, Walsh SLF, Kolb M, Koschel D, Moua T, Stowasser S, Goeldner RG, Schlenker-Herceg R, Brown KK, INBUILD Trial Investigators. Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. Eur Respir J. 2022 Mar; 59 (3) Epub 2022 Mar 17
    View PubMed
22. Hill M, Petnak T, Moua T. Bronchoalveolar lavage lymphocytosis in hypersensitivity pneumonitis: a retrospective cohort analysis with elimination of incorporation bias. BMC Pulm Med. 2022 Feb 1; 22 (1):49 Epub 2022 Feb 01
    View PubMed
23. Charokopos A, Moua T, Ryu JH, Smischney NJ. Acute exacerbation of interstitial lung disease in the intensive care unit. World J Crit Care Med. 2022 Jan 9; 11 (1):22-32 Epub 2022 Jan 09
    View PubMed
24. Petnak T, Lertjitbanjong P, Thongprayoon C, Moua T. Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Chest. 2021 Nov; 160 (5):1751-1763 Epub 2021 July 02
    View PubMed
25. De Giacomi F, White D, Decker PA, Vaszar LT, Sandbo N, Lee AS, Ryu JH, Moua T. Derivation and validation of a prediction model for histopathologic fibrotic hypersensitivity pneumonitis. Respir Med. 2021 Oct; 187:106598 Epub 2021 Aug 30
    View PubMed
26. Kelly BT, Thao V, Dempsey TM, Sangaralingham LR, Payne SR, Teague TT, Moua T, Shah ND, Limper AH. Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications. BMC Pulm Med. 2021 Jul 17; 21 (1):239 Epub 2021 July 17
    View PubMed
27. Colbenson GA, Dempsey TM, Cecchini MJ, Aubry MC, Moua T, Ryu JH. A Bodybuilder with Dyspnea and Hypercalcemia. Am J Med. 2021 Jun; 134 (6):e363-e365 Epub 2020 Dec 11
    View PubMed
28. Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative. Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA. 2021 May 11; 325 (18):1841-1851
    View PubMed
29. Castelino FV, Moua T. Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases. ACR Open Rheumatol. 2021 May; 3 (5):295-304 Epub 2021 Mar 28
    View PubMed
30. Baqir M, Vasirreddy A, Vu AN, Moua T, Chamberlain AM, Frank RD, Ryu JH. Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study. Respir Med. 2021 Mar; 178:106309 Epub 2021 Jan 22
    View PubMed
31. Lee AS, Scofield RH, Hammitt KM, Gupta N, Thomas DE, Moua T, Ussavarungsi K, St Clair EW, Meehan R, Dunleavy K, Makara M, Carsons SE, Carteron NL, Consensus Expert Panel (CEP) Members. Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjogren's. Chest. 2021 Feb; 159 (2):683-698 Epub 2020 Oct 16
    View PubMed
32. Moua T, Kubbara A, Novotny P, Ridgeway JL, Limper AH, Ryu JH, Clark MM, Benzo R. Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect. ERJ Open Res. 2021 Jan; 7(1). Epub 2021 Mar 08.
    View PubMed
33. He C, Marll M, Matson S, Bianchi P, Cosgrove GP, Lee JS, PFF CCN Delphi Collaborators. Essential Components of an Interstitial Lung Disease Clinic: Results from a Delphi Survey and Patient Focus Group Analysis. Chest. 2020 Oct 5 Epub 2020 Oct 05
    View PubMed
34. Nasim F, Moua T. Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis. ERJ Open Res. 2020 Oct; 6 (4) Epub 2020 Dec 14
    View PubMed
35. Koslow M, Edell ES, Midthun DE, Mullon JJ, Kern RM, Nelson DR, Sakata KK, Moua T, Roden AC, Yi ES, Reisenauer JS, Decker PA, Ryu JH. Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical Practice. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):565-574 Epub 2020 Oct 06
    View PubMed
36. Moua T. Diagnostic value of TBLC in idiopathic pulmonary fibrosis. Lancet Respir Med 2020 Aug; 8 (8):747-748
    View PubMed
37. Martin MJ, Moua T. Mechanical Ventilation and Predictors of In-Hospital Mortality in Fibrotic Interstitial Lung Disease With Acute Respiratory Failure: A Cohort Analysis Through the Paradigm of Acute Respiratory Distress Syndrome. Crit Care Med. 2020 Jul; 48 (7):993-1000
    View PubMed
38. Gao Y, Moua T, Midthun DE, Mullon JJ, Decker PA, Ryu JH. Diagnostic Yield and Bleeding Complications Associated With Bronchoscopic Biopsy of Endobronchial Carcinoid Tumors. J Bronchology Interv Pulmonol. 2020 Jul; 27 (3):184-189
    View PubMed
39. Zaman T, Moua T, Vittinghoff E, Ryu JH, Collard HR, Lee JS. Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis: A Multicenter Retrospective Cohort Study. Chest. 2020 Jul; 158 (1):245-251 Epub 2020 Feb 19
    View PubMed
40. Petnak T, Moua T. Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire. ERJ Open Res. 2020 Jul; 6 (3) Epub 2020 Sept 28
    View PubMed
41. Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020 May; 8 (5):453-460 Epub 2020 Mar 05
    View PubMed
42. Baqir M, Roden AC, Moua T. Amyloid in the Lung. Semin Respir Crit Care Med. 2020 Apr; 41 (2):299-310 Epub 2020 Apr 12
    View PubMed
43. Baqir M, Moua T, White D, Yi ES, Ryu JH. Pulmonary nodular and cystic light chain deposition disease: A retrospective review of 10 cases. Respir Med. 2020 Apr; 164:105896 Epub 2020 Feb 14
    View PubMed
44. Gao Y, Moua T. Treatment of the Connective Tissue Disease-Related Interstitial Lung Diseases: A Narrative Review. Mayo Clin Proc. 2020 Mar; 95 (3):554-573
    View PubMed
45. Gao Y, Egan AM, Moua T. Dendriform pulmonary ossification complicated by recurrent spontaneous pneumothorax: Two case reports and a review of the literature. Respir Med Case Rep. 2020; 30:101067 Epub 2020 Apr 23
    View PubMed
46. Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK, INBUILD Trial Investigators. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019 Oct 31; 381 (18):1718-1727 Epub 2019 Sept 29
    View PubMed
47. Moua T, Lee AS, Ryu JH. Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2019 Oct; 13 (10):993-1004 Epub 2019 Aug 26
    View PubMed
48. De Giacomi F, Baqir M, Cox CW, Moua T, Matteson EL, Ryu JH. Spontaneous Pneumomediastinum in Connective Tissue Diseases. J Clin Rheumatol. 2019 Sep; 25 (6):239-245
    View PubMed
49. Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, Moua T, van Beek FT, Clay R, Veltkamp M, Kokosi M, de Lauretis A, Judge EP, Jacob TM, Peikert T, Karwoski R, Maldonado F, Renzoni E, Maher TM, Altmann A, Wells AU. Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis. Eur Respir J 2019 Sep; 54 (3) Epub 2019 Sept 30
    View PubMed
50. Vu A, Vasireddy A, Moua T, Baqir M, Ryu JH. Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study. Eur Respir J 2019 Jul; 54 (1) Epub 2019 July 04
    View PubMed
51. Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, SENSCIS Trial Investigators. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019 Jun 27; 380 (26):2518-2528 Epub 2019 May 20
    View PubMed
52. Moua T, Ryu JH. Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives. Ther Clin Risk Manag. 2019; 15:73-81 Epub 2019 Jan 03
    View PubMed
53. Alsumrain M, De Giacomi F, Nasim F, Koo CW, Bartholmai BJ, Levin DL, Moua T. Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival. Respir Med. 2019 Jan; 146:106-112 Epub 2018 Dec 13
    View PubMed
54. Holtze C, Flaherty K, Kreuter M, Luppi F, Moua T, Vancheri C, Scholand MB. Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018 Dec 31; 27 (150) Epub 2018 Dec 21
    View PubMed
55. Kelly B, Moua T. Usual interstitial pneumonia: A distinct group within interstitial pneumonia with autoimmune features? - Reply. Respirology 2018 Oct; 23 (10):959 Epub 2018 Aug 02
    View PubMed
56. De Giacomi F, White D, Cox CW, Moua T. Evolution of diagnostic UIP computed tomography patterns in idiopathic pulmonary fibrosis: Disease spectrum and implications for survival. Respir Med. 2018 Sep; 142:53-59 Epub 2018 July 25
    View PubMed
57. Lin E, Limper AH, Moua T. Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series. BMC Pulm Med. 2018 Jun 22; 18 (1):105 Epub 2018 June 22
    View PubMed
58. Kelly BT, Moua T. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology. 2018 Jun; 23 (6):600-605 Epub 2018 Jan 10
    View PubMed
59. Azadeh N, Moua T, Baqir M, Ryu JH. Treatment of acute exacerbations of interstitial lung disease. Expert Rev Respir Med. 2018 Apr; 12 (4):309-313 Epub 2018 Mar 12
    View PubMed
60. De Giacomi F, Raghunath S, Karwoski R, Bartholmai BJ, Moua T. Short-term Automated Quantification of Radiologic Changes in the Characterization of Idiopathic Pulmonary Fibrosis Versus Nonspecific Interstitial Pneumonia and Prediction of Long-term Survival. J Thorac Imaging. 2018 Mar; 33 (2):124-131
    View PubMed
61. Alsumrain M, De Giacomi F, Mirza S, Moua T. Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review. Respir Res. 2017 Aug 23; 18 (1):161
    View PubMed
62. Arcadu A, Byrne SC, Pirina P, Hartman TE, Bartholmai BJ, Moua T. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis. Respir Med. 2017 Aug; 129:152-157 Epub 2017 June 21
    View PubMed
63. Woge MJ, Ryu JH, Moua T. Diagnostic implications of positive avian serology in suspected hypersensitivity pneumonitis. Respir Med. 2017 Aug; 129:173-178 Epub 2017 June 27
    View PubMed
64. Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection. 2017 Aug; 45 (4):443-448 Epub 2017 Feb 20
    View PubMed
65. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE Jr, Wolters PJ, Collard HR, Ley B. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017 May; 72 (5):424-429 Epub 2017 Jan 12
    View PubMed
66. Arcadu A, Moua T. Bronchoscopy assessment of acute respiratory failure in interstitial lung disease. Respirology. 2017 Feb; 22 (2):352-359 Epub 2016 Oct 06
    View PubMed
67. Carrera P, Thongprayoon C, Cheungpasitporn W, Iyer VN, Moua T. Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit. J Crit Care. 2016 Dec; 36:102-106 Epub 2016 July 09
    View PubMed
68. Teeters DA, Moua T, Li G, Kashyap R, Biehl M, Kaur R, Gajic O, Boeve BF, St Louis EK, Petersen RC, Caples SM. Mild Cognitive Impairment and Risk of Critical Illness. Crit Care Med. 2016 Nov; 44 (11):2045-2051
    View PubMed
69. Gallo de Moraes A, Vakil A, Moua T. Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity. Respir Med. 2016 Sep; 118:53-57 Epub 2016 July 15
    View PubMed
70. Zamora AC, Hoskote SS, Abascal-Bolado B, White D, Cox CW, Ryu JH, Moua T. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med. 2016 Sep; 118:39-45. Epub 2016 Jul 16.
    View PubMed
71. Arcadu A, Moua T, Yi ES, Ryu JH. Lymphoid Interstitial Pneumonia and Other Benign Lymphoid Disorders. Semin Respir Crit Care Med. 2016 Jun; 37 (3):406-20 Epub 2016 May 27
    View PubMed
72. Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis. Chest. 2016 May; 149 (5):1205-14 Epub 2016 Jan 11
    View PubMed
73. Zamora Martinez AC, Zamora AC, White DB, Sykes AM, Hoskote SS, Moua T, Yi ES, Ryu JH. Amyloid-associated Cystic Lung Disease. Chest. 2016 May; 149 (5):1223-33 Epub 2016 Jan 12
    View PubMed
74. Ryu JH, Moua T, Azadeh N, Baqir M, Yi ES. Current concepts and dilemmas in idiopathic interstitial pneumonias. F1000Res. 2016; 5:2661 Epub 2016 Nov 10
    View PubMed
75. Gallo de Moraes A, Patel PA, Mahal E, Kramer CL, Diaz Soto JC, Moua T. Acute fever and seizure in a patient with recent atrial fibrillation ablation. Heart Lung. 2015 Jul-Aug; 44 (4):314-6 Epub 2015 May 26
    View PubMed
76. Reddy DR, O'Horo JC, Hoskote SS, Moua T. Judgment of futile care in the ICU. Crit Care Med 2015 May; 43 (5):e151
    View PubMed
77. Moua T, Zamora Martinez AC, Baqir M, Vassallo R, Limper AH, Ryu JH. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res. 2014 Dec 4; 15:154 Epub 2014 Dec 04
    View PubMed
78. Ryu JH, Moua T, Daniels CE, Hartman TE, Yi ES, Utz JP, Limper AH. Idiopathic pulmonary fibrosis: evolving concepts. Mayo Clin Proc. 2014 Aug; 89 (8):1130-42 Epub 2014 May 24
    View PubMed
79. Maldonado F, Moua T, Skalski J. Parenchymal cryobiopsies for interstitial lung diseases: a step forward in disease management. Respirology 2014 Aug; 19 (6):773-4 Epub 2014 June 26
    View PubMed
80. Moua T, Maldonado F, Decker PA, Daniels CE, Ryu JH. Frequency and implication of autoimmune serologies in idiopathic pulmonary fibrosis. Mayo Clin Proc. 2014 Mar; 89(3):319-26.
    View PubMed
81. Ryu JH, Moua T, Monter-Arias F, Yi ES. Update on idiopathic interstitial pneumonias. Shortness of Breath. 2014; 3:3-11.
    
82. Raghunath S, Rajagopalan S, Karwoski RA, Maldonado F, Peikert T, Moua T, Ryu JH, Bartholmai BJ, Robb RA. Quantitative stratification of diffuse parenchymal lung diseases. PLoS One. 2014; 9 (3):e93229 Epub 2014 Mar 27
    View PubMed
83. Moua T, Zand L, Hartman RP, Hartman TE, Qin D, Peikert T, Qian Q. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS One. 2014; 9 (4):e93674 Epub 2014 Apr 18
    View PubMed
84. Maldonado F, Moua T, Rajagopalan S, Karwoski RA, Raghunath S, Decker PA, Hartman TE, Bartholmai BJ, Robb RA, Ryu JH. Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J. 2014 Jan; 43 (1):204-12 Epub 2013 Apr 05
    View PubMed
85. Moua T, Aksamit TR. Diagnosis and managment of nontuberculous mycobacterial lung infections. Current Respiratory Care Reports. 2014; 3:161-169.
    
86. Lee SJ, Cawcutt K, Moua T. Antimicrobial guidance in ventilator-associated pneumonia with routine endotracheal cultures. Chest. 2014; 145(4):925.
    
87. Bartholmai BJ, Raghunath S, Karwoski RA, Moua T, Rajagopalan S, Maldonado F, Decker PA, Robb RA. Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging. 2013 Sep; 28 (5):298-307
    View PubMed
88. Moua T, Rizza SA, Kennedy CC. Leg weakness in a lung transplant patient. Transpl Infect Dis. 2013 Jun; 15(3):E102-6. Epub 2013 Apr 14.
    View PubMed
89. Moua T, Levin DL, Carmona EM, Ryu JH. Frequency of mediastinal lymphadenopathy in patients with idiopathic pulmonary arterial hypertension. Chest. 2013 Feb 01; 143: (2)344-348.
    View PubMed
90. Moua T, Olson EJ, St HC, Jean HC, Ryu JH. Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy. Am J Respir Crit Care Med. 2012 Aug 15; 186: (4)389-90.
    View PubMed
91. Carmona EM, Kottom TJ, Hebrink DM, Moua T, Singh RD, Pagano RE, Limper AH. Glycosphingolipids mediate pneumocystis cell wall beta-glucan activation of the IL-23/IL-17 axis in human dendritic cells. Am J Respir Cell Mol Biol. 2012 Jul; 47 (1):50-9 Epub 2012 Feb 16
    View PubMed
92. Cuffe S, Moua T, Summerfield R, Roberts H, Jett J, Shepherd FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol. 2011 Apr; 6(4):818-22.
    View PubMed
93. Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, Young A, De Cicco M, Biffi R, van Rooden CJ, Huisman MV, Fagnani D, Cimminiello C, Moia M, Magagnoli M, Povoski SP, Malak SF, Lee AY. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011 Feb; 9(2):312-9.
    View PubMed
94. Moua T, Wood KE, Atwater BD, Runo JR. Major pulmonary embolism and hemodynamic stability from shunting through a patent foramen ovale. South Med J. 2008 Sep; 101(9):955-8.
    View PubMed
95. Moua T, Wood K. COPD and PE: a clinical dilemma. Int J Chron Obstruct Pulmon Dis. 2008; 3(2):277-84.
    View PubMed